Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.
MRMD
$0.06
-2.63%
MRMD
· Marimed Inc.
Market Cap
$22.57M
Shares
403.04M
Volume · Oct 20
131.65K
Avg daily vol (3M)
561.09K
All webcasts
Earnings call · FY2024 Q2
Marimed Inc. (MRMD) Q2 2024 Earnings Call
Revenue
$40.44M
+10.7% YoY
Diluted EPS
$0.00
Gross margin
41.8%
-3.0 pp YoY
Net income
-$1.65M
Forward guidance
2 guided metrics
Management's latest ranges and targets are included below.
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Research materials
Open the source you need; every reader stays inside this workspace.
Forward guidance
From the 8-K filed Aug 7, 2024.
| Metric | Period | Guided | Basis |
|---|---|---|---|
|
Non-GAAP Adjusted EBITDA growth
Maintained
full year 2024
|
0% – 2% | Non-GAAP | |
|
Capital expenditures
Maintained
full year 2024
|
$10M | — |
Quarter detail
How the reported period landed and where the business moved.
SEC filing · Item 2.02
8-K earnings release
Filed Aug 7, 2024 · complete as-filed document
SEC periodic report
10-Q report
Filed Aug 8, 2024 · complete as-filed document